INTRODUCTION
============

Idiopathic chronic pancreatitis associated with minimal clinical symptoms, icterus and notable hypergammaglobulinaemia was first described in 1961 by Sarles et al.[@B1]

In 1995, Yoshida et al.[@B2] documented a case of a 68-year-old woman with obstructive icterus, diffusely enlarged pancreas with irregular caliber of pancreatic duct (without significant stenosis or dilatations), significantly increased γ-globulin levels, and histologically verified pancreatic fibrosis. Steroid treatment led to amelioration of clinical symptoms and morphological changes. This disease was labeled autoimmune pancreatitis (AIP; as a parallel for autoimmune hepatitis).

AIP is currently classified into two subgroups.[@B3] Type 1 AIP, also known as lymphoplasmacytic sclerosing pancreatitis (LPSP), usually affects men between 50 and 60 years of age, with histological findings of periductal lymphoplasmacytic infiltrates, oblitering arteritis, and excessive fibroproduction.[@B4],[@B5] In 95% to 98% of cases, AIP type 1 is accompanied by immunoglobulin G4 (IgG4) positivity in tissue samples and/or elevated IgG4 levels in blood serum. AIP type 1 is frequently combined with simultaneous involvement of extrapancreatic organs (e.g., sclerosing cholangitis,[@B6] retroperitoneal fibrosis,[@B7] IgG4 positive tubulointestitial nephritis,[@B8] chronic sclerosing sialadenitis,[@B9] and sicca syndrome[@B10]) and other extrapancreatic lesions.

In contrast, AIP type 2 is most commonly diagnosed in the fourth decade of life, with the same incidence in men and women and is usually combined with the presence of inflammatory bowel disease. IgG4 positive biopsy and/or elevated IgG4 serum levels (diagnostic for AIP type 1) are usually absent in AIP type 2. Besides the lymphoplasmacytic infiltrates, typical histological findings of AIP type 2 also include ductuli destructing inflammation with granulocytic epithelial lesions with partial or full obstruction of the pancreatic ducts.[@B11] The presence of icterus is uncommon.[@B12]

We present a case report of concurrent findings of AIP, IgG4 positive mastitis, and Mikulicz syndrome. A publication of unidentified case reports is allowed by Ethical Committee of the University Hospital Brno.

CASE REPORT
===========

A 58-year-old woman was referred to our institution for nonspecific dyspepsia. She had been medically followed for several years for recurring mastitis of unclear etiology.

Medical history was significant for thyroiditis diagnosed in 1976. For the last 3 years, she was followed by the Department of Ophthalmology, University Hospital Brno for histologically verified Mikulicz syndrome. Subsequently, salivary function was also tested, but only nonsignificant decrease in function was revealed.

In 2006, the patient noticed right-sided submandibular induration; extirpation was carried out for suspected malignancy which was ruled out by histological findings of a fibrotised salivary gland.

In 2009, she was examined by the oncology department for recurring mastitis; biopsy findings showed IgG4 infiltrates ([Figs 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). A gastroenterology consult was then recommended for the patient\'s dyspepsia.

Based on the patient\'s prior medical history, AIP was strongly suspected; therefore, serum immunoglobulin levels were tested. Total IgG was elevated (29.77 g/L; normal range, 7 to 16 g/L); IgG4 was more than 3-times the normal limit (920 mg/L; normal range, 8 to 140 mg/L) and rheumatoid factor and antipancreatic duct antibodies also tested positive. According to Japanese criteria, the findings indicated AIP with synchronous IgG4 mastitis and Mikulicz syndrome.

Abdominal sonography and computed tomography revealed the typical picture of AIP-an enlarged sausage-like pancreas. The steroid treatment led to a normalization of sonographic finding ([Figs 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

Further endosonography confirmed a diffusely enlarged pancreas with rough, unclear outlines, and a small caliber duct.

The patient was treated with prednisone at an initial dose of 40 mg for 2 weeks. The dose was then tapered by 5 mg with a maintenance dose of 10 mg of prednisone prescribed for 3 months.

The patient has been followed for 1 year after completion of steroid treatment and she is symptoms free with normalized biochemical and sonographic findings. Additionally, the mastitis did not recur during the 12 months period.

DISCUSSION
==========

It is widely accepted that AIP is a part of multisystem disorder characterized by histomorphologic changes with concurrent presence of immunoglobin IgG4 in blood plasma and/or tissues.[@B13],[@B14] As such, the term IgG4 related sclerosing disease is used for this entity by some authors.[@B15],[@B16]

AIP is frequently associated with simultaneous involvement of extrapancreatic organs, in particular the hepatobiliary system,[@B6] kidneys,[@B17] salivary glands, retroperitoneal fibrosis, and pulmonary impairment.[@B7],[@B9],[@B18],[@B19]

Currently, AIP is divided into two subgroups. AIP type 1, which is more common, has symptoms and diagnostic criteria equivalent to disorders described in earlier literature as an autoimmune form of pancreatitis or LPSP.[@B4] This type of AIP is often accompanied by concurrent extrapancreatic disorders and has recently been considered to be a part of IgG4 associated systemic disease.[@B13] Findings of high levels of IgG4 immunoglobulin in blood serum and/or affected tissues with their progressive fibrotization are typical for this diagnostic entity.

The presented case report documents a patient with histologically verified Mikulicz syndrome and recurring mastitis who we diagnosed with concurrent AIP. Asian criteria[@B20] were used for the AIP diagnosis, since the pancreas involvement was not focal and therefore, biopsy necessary for HISORt classification system[@B21] was not indicated.

While IgG4-related sclerosing mastitis has been described before,[@B22] to the best of our knowledge, this is the first reported case of concurrent findings of AIP and IgG4 positive mastitis. Levels of IgG4 tested highly positive both in blood serum and breast biopsy. Steroid treatment improved patient\'s dyspepsia making the AIP diagnosis even more likely. Neither AIP symptoms, nor mastitis recurred within the 12 months period following termination of steroid treatment.

The probability of AIP recurrence after steroid withdrawal is 30% to 50%.[@B23]-[@B25] In this case, steroid, or azathioprine treatment would be indicated.[@B26],[@B27]

In conclusion, by adding an additional organ affected with IgG4 derived inflammation, our findings support a concept of AIP as a systemic IgG4 disease with multisystem involvement.
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![(A) Sonographic picture of enlarged sausage-like pancreas prior to steroid treatment and (B) normalization of this finding after 6 months of steroid treatment.](gnl-7-621-g003){#F3}
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